Pointe Capital Management »

Regeneron Pharmaceuticals shares owned by Pointe Capital Management

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Pointe Capital Management from 13F filings

Historical chart of Pointe Capital Management investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Pointe Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Pointe Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $404k 719 562.27
2025-06-30 $276k 525 525.00
2025-03-31 $329k 519 634.23
2024-12-31 $376k 528 712.33
2024-09-30 $359k 341 1051.24
2023-03-31 $109k 132 821.67
2022-06-30 $399k 571 698.77
2022-03-31 $399k 571 698.77
2021-12-31 $352k 557 631.96